TRANSFORM Alliance’s Post

🎙“Challenges across Europe are affecting these three areas: we need to incentivise innovation, we need to balance it with sustainability and affordability, and we need to drive value and access in our healthcare systems.”   💊Adam Parnaby from Bristol Myers Squibb spoke during one of our panels on the need to future-proof EU healthcare by taking a holistic, drug lifecycle approach: while it is crucial that research and innovation are supported and incentivised, solutions must also be designed for the challenges awaiting developers further down the drug development process. New tools are needed to ensure that regulators and assessors are able to capture ATMP clinical evidence in a way that is then translatable to healthcare systems, allowing them to make intelligent, future-oriented reimbursement decisions.   🧬Make sure to follow our LinkedIn page for more forceful messages from the annual TRANSFORM MEP Interest Group Conference. Check out our website for more information on our MEP Interest Group: https://lnkd.in/eFWDMeuv #MEPsforATMPs #cellandgenetherapy #EuropeanParliament #innovation #competitiveness #HTA

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics